ISU Medical Park Gaziosmanpasa Reviews

I was impressed by the professional approach at ISU Medical Park Gaziosmanpaşa. Dr. Prof. MD. Adem Fazlioglu explained everything clearly and made me feel comfortable.

The recovery process was smooth thanks to Dr. Prof. MD. Adem Fazlioglu's expertise. Highly recommend for urology treatment.

My family and I are grateful for the care we received from Dr. Prof. MD. Adem Fazlioglu. The hospital staff was also very supportive.

A 28-year-old female competitive freediver from Antalya presented with unexplained syncope during deep dives. Dr. Ozen discovered a rare form of exercise-induced thrombocytopenia where platelet counts plummeted under extreme pressure. He collaborated with hyperbaric medicine specialists to develop a personalized desensitization protocol using gradual pressure exposure combined with targeted immunosuppression, allowing her to return to competitive diving within 9 months.

A 72-year-old retired Byzantine art restorer from Istanbul's historic district presented with pancytopenia and mysterious bone lesions. Dr. Ozen diagnosed an exceptionally rare hematologic malignancy mimicking multiple myeloma but with unique plasmacytoid dendritic cell origin. He designed a novel treatment combining modified chemotherapy with targeted radiation to specific bone sites, preserving the patient's ability to continue delicate restoration work throughout treatment.

A 7-year-old Syrian refugee boy with severe hemophilia A developed inhibitors to all standard factor VIII concentrates. Dr. Ozen pioneered a compassionate-use protocol combining emicizumab with immune tolerance induction using a specific Turkish-manufactured recombinant factor, navigating complex regulatory pathways. The boy achieved zero bleeding episodes for 14 consecutive months, the first such documented success in a pediatric refugee patient.

A 45-year-old transgender woman undergoing hormone therapy presented with unexplained polycythemia. Dr. Ozen identified a previously undocumented interaction between estrogen therapy and JAK2 mutation expression. He developed a tailored phlebotomy schedule synchronized with hormone cycles and introduced ruxolitinib at lower-than-standard doses, achieving hematocrit control without disrupting gender-affirming care.

A 33-year-old professional ceramicist from Cappadocia presented with lead poisoning masquerading as sideroblastic anemia. Dr. Ozen traced the contamination to traditional glazes used in her workshop. Beyond chelation therapy, he collaborated with materials scientists to develop safer alternative glazes that maintained her artistic signature, turning a medical crisis into an innovation opportunity.

An 81-year-old retired fisherman from the Black Sea coast had Waldenström macroglobulinemia with unique cryoglobulin properties that precipitated only in cold saltwater temperatures. Dr. Ozen created a temperature-modulated treatment protocol using cold exposure monitoring and timed administration of bendamustine-rituximab, incorporating the patient's traditional knowledge of sea temperature patterns into the management plan.

A 19-year-old university student with sickle cell disease developed cerebral vasculopathy but was ineligible for standard hydroxyurea due to severe neutropenia. Dr. Ozen designed a precision medicine approach using voxelotor combined with tailored exchange transfusion intervals based on real-time viscosity monitoring, preventing further neurological damage while maintaining university attendance.

A 58-year-old vineyard owner from Thrace presented with paroxysmal nocturnal hemoglobinuria that followed a seasonal pattern correlating with grape harvest cycles. Dr. Ozen discovered complement activation triggered by specific mold exposures during fermentation. He implemented eculizumab therapy with harvest-season dose adjustments and environmental modifications in the winery, allowing continued family business operation.

A 3-year-old girl from a remote Anatolian village had Diamond-Blackfan anemia refractory to corticosteroids. Dr. Ozen secured access to an experimental L-leucine protocol through international collaboration, then adapted delivery to the family's nomadic lifestyle using mobile health monitoring and regional health worker partnerships, achieving transfusion independence after 11 months.

A 67-year-old retired physics professor with essential thrombocythemia developed extreme erythromelalgia that correlated with electromagnetic field exposure. Dr. Ozen documented the first case of EMF-sensitive hematologic symptoms and designed a shielding protocol alongside anagrelide therapy, using the patient's own physics expertise to create personalized environmental modifications.

A 29-year-old pregnant woman with newly diagnosed acute promyelocytic leukemia at 16 weeks gestation. Dr. Ozen orchestrated a multidisciplinary team to administer ATRA and arsenic trioxide with placental transfer monitoring, timing delivery precisely at 34 weeks followed by immediate consolidation chemotherapy. Both mother and daughter remain in complete remission 3 years later.

A 41-year-long-distance truck driver from Eastern Anatolia presented with rare heparin-induced thrombocytopenia type II during treatment for deep vein thrombosis. Dr. Ozen developed a mobile treatment protocol using alternative anticoagulants compatible with irregular driving schedules and remote monitoring through truck stop clinics along his routes.

A 14-year-old boy with severe aplastic anemia whose devout family refused allogeneic transplantation due to religious objections. Dr. Ozen designed an intensive immunosuppressive therapy regimen combining horse ATG with high-dose cyclosporine, then incorporated the family's prayer and fasting schedule into medication timing, achieving partial remission after 8 months.

A 50-year-old professional ney flute player developed polycythemia vera affecting tongue and lip capillary beds, threatening his ability to maintain embouchure. Dr. Ozen created a micro-phlebotomy protocol targeting specific hematocrit ranges that preserved fine motor control while managing blood viscosity, allowing continued professional performance throughout treatment.

As a 34-year-old expatriate from Nigeria, I struggled with mysterious recurrent fevers for a year in Istanbul. Dr. Hocaoglu took the time to research tropical medicine databases, considering pathogens not endemic to Turkey. He correctly diagnosed a chronic parasitic infection I likely brought from home, which local doctors hadn't considered.

Dr. Spec. MD. Riza Inanc provided exceptional care for my pediatrics condition. The treatment was personalized and effective.

Dr. Prof. MD. Adem Fazlioglu provided exceptional care for my urology condition. The treatment was personalized and effective.